Literature DB >> 8075631

Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q.

M R Stratton1, D Ford, S Neuhasen, S Seal, R Wooster, L S Friedman, M C King, V Egilsson, P Devilee, R McManus.   

Abstract

Breast cancer in men is about a hundredfold less common than in women and this has hindered research into its genetic basis. We have examined 22 families with at least one case of male breast cancer for linkage to the hereditary breast and ovarian cancer locus, BRCA1, on chromosome 17q. We found strong evidence against linkage to BRCA1 (lod score-16.63) and the best estimate of the proportion of linked families was 0% (95% CI 0-18%). Our results indicate that there is a gene(s) other than BRCA1 which predisposes to early-onset breast cancer in women and which confers a higher risk of male breast cancer. Identification of additional pedigrees that include cases of male breast cancer may therefore facilitate the mapping and isolation of this gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8075631     DOI: 10.1038/ng0594-103

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  34 in total

1.  Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5.

Authors:  Jessica Amlin-Van Schaick; Sungjin Kim; Karl W Broman; Karlyne M Reilly
Journal:  Mamm Genome       Date:  2011-12-08       Impact factor: 2.957

Review 2.  An updated review of epidemiology, risk factors, and management of male breast cancer.

Authors:  Noman Ahmed Jang Khan; Maria Tirona
Journal:  Med Oncol       Date:  2021-03-15       Impact factor: 3.064

3.  The Bermuda Triangle: The Pragmatics, Policies, and Principles for Data Sharing in the History of the Human Genome Project.

Authors:  Kathryn Maxson Jones; Rachel A Ankeny; Robert Cook-Deegan
Journal:  J Hist Biol       Date:  2018-12       Impact factor: 1.326

4.  BRCA1 and BRCA2 mutations and treatment strategies for breast cancer.

Authors:  Inês Godet; Daniele M Gilkes
Journal:  Integr Cancer Sci Ther       Date:  2017-02-27

Review 5.  Effect of BRCA2 mutation on familial breast cancer survival: A systematic review and meta-analysis.

Authors:  Jun Shao; Jie Yang; Jun-Nai Wang; Long Qiao; Wei Fan; Qing-Lei Gao; Yao-Jun Feng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

6.  The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology.

Authors:  B Newman; P G Moorman; R Millikan; B F Qaqish; J Geradts; T E Aldrich; E T Liu
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

7.  Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer.

Authors:  R S Cornelis; H F Vasen; H Meijers-Heijboer; D Ford; M van Vliet; A A van Tilborg; F J Cleton; J G Klijn; F H Menko; P Meera Khan
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

8.  A large multisite cancer family is linked to BRCA2.

Authors:  P Tonin; P Ghadirian; C Phelan; G M Lenoir; H T Lynch; F Letendre; D Belanger; M Monté; S A Narod
Journal:  J Med Genet       Date:  1995-12       Impact factor: 6.318

9.  BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer.

Authors:  Mahnaz Razandi; Ali Pedram; Eliot M Rosen; Ellis R Levin
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 10.  Understanding and management of male breast cancer: a critical review.

Authors:  Kartikeya Pant; Udayan Dutta
Journal:  Med Oncol       Date:  2007-12-12       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.